Last reviewed · How we verify
Xilytol tablet to limit dental biofilm — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Xilytol tablet to limit dental biofilm (Xilytol tablet to limit dental biofilm) — Universidade Federal do Rio de Janeiro.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Xilytol tablet to limit dental biofilm TARGET | Xilytol tablet to limit dental biofilm | Universidade Federal do Rio de Janeiro | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Xilytol tablet to limit dental biofilm CI watch — RSS
- Xilytol tablet to limit dental biofilm CI watch — Atom
- Xilytol tablet to limit dental biofilm CI watch — JSON
- Xilytol tablet to limit dental biofilm alone — RSS
Cite this brief
Drug Landscape (2026). Xilytol tablet to limit dental biofilm — Competitive Intelligence Brief. https://druglandscape.com/ci/xilytol-tablet-to-limit-dental-biofilm. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab